Bulevirtide acetate
Bulevirtide acetate is a synthetic lipopeptide that inhibits the hepatitis B and D virus entry receptor, NTCP. It is a valuable research tool for investigating viral entry mechanisms and evaluating antiviral strategies in both in vitro and in vivo models of HBV/HDV co-infection.
Product Specifications
Product Name Alternative
Bulevirtide (Myrcludex B) acetate, Bulevirtide (Myrcludex B) Acetate, HBV
Field of Research
Infectious Disease & Virology
Purity
98.27% (May vary between batches)
Solubility
DMSO:100 mg/mL (18.32 mM) ; H2O:Insoluble
Molecular Weight
5458.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OM10949-01 100 mg
4-Methoxyphenyl 4-O-[3,6-di-O-benzyl-2-deoxy-4-O- (4,6-O-benzylidene-2-O-levulinoyl-b-D-glucopyranosyl) -2-phthalimido-b-D-glucopyrano sy]-3-O-benzyl-2-deoxy-6-O- (4-methoxybenzyl) -2-phthalimido-b-D-glucopyranoside
Sign In for Pricing
View Details OM10949-02 250 mg
4-Methoxyphenyl 4-O-[3,6-di-O-benzyl-2-deoxy-4-O- (4,6-O-benzylidene-2-O-levulinoyl-b-D-glucopyranosyl) -2-phthalimido-b-D-glucopyrano sy]-3-O-benzyl-2-deoxy-6-O- (4-methoxybenzyl) -2-phthalimido-b-D-glucopyranoside
Sign In for Pricing
View Details OM10949-03 500 mg
4-Methoxyphenyl 4-O-[3,6-di-O-benzyl-2-deoxy-4-O- (4,6-O-benzylidene-2-O-levulinoyl-b-D-glucopyranosyl) -2-phthalimido-b-D-glucopyrano sy]-3-O-benzyl-2-deoxy-6-O- (4-methoxybenzyl) -2-phthalimido-b-D-glucopyranoside
Sign In for Pricing
View Details